Principal Financial Group
TIL icon

Principal Financial Group’s Instil Bio TIL Stock Holding History

Principal Financial Group’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,352
Closed -$17.9K – 2486
2023
Q1 		$17.9K Buy
1,352
+1
+0.1% +$15 ﹤0.01% 2430
2022
Q4 		$17K Buy
+1,351
New +$66.8K ﹤0.01% 2408

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group's TIL Position: Q2 2023 in Review

Principal Financial Group sold out of Instil Bio (TIL) in Q2 2023, closing a stake of 1,352 shares — an estimated $17.9K sold.

Principal Financial Group first reported a position in TIL in Q4 2022 and held it in 2 quarters. The position peaked at $17.9K in Q1 2023. 62 funds tracked by Wall St. Rank hold TIL as of Q2 2023.

  • Principal Financial Group reported no remaining Instil Bio position as of Q2 2023 after selling out during the quarter.
  • Principal Financial Group sold 1,352 Instil Bio shares in Q2 2023, an estimated $17.9K.
  • Principal Financial Group first reported a position in Instil Bio in Q4 2022 and held it in 2 quarters.
  • Principal Financial Group's Instil Bio position peaked at $17.9K in Q1 2023.
  • 62 funds tracked by Wall St. Rank held Instil Bio as of Q2 2023.

Based on Principal Financial Group's 13F filing for Q2 2023, filed 7 Aug 2023.